Dr. Naresh Shanmugam, India Oral
Clinical utility of Donor-Derived cell-free DNA (ddcfDNA) in non-invasive monitoring of Liver transplant recipients

Dr. Akhmet Seidakhmetov, Japan Oral
Combination of SIRPa genotype in recipient and donor modulates immune response after living donor liver transplantation

Dr. Takahiro Tomiyama, Japan Oral
Up-regulated LRRN2 expression is effective as a marker for graft quality in living donor liver transplantation

Dr. Christina Bogensperger, Austria Oral
Changes of Glutathione excretion during normothermic machine perfusion of livers and potential influencing transplant factors

Dr. David Pereyra, Austria Oral
Hypothermic Oxygenated Machine Perfusion of the Liver via Hepatic Artery and Portal Vein Reduces Biliary Complications

Dr. Julia Hofmann PhD, Austria Oral
Long-term ex situ normothermic machine perfusion: Red-blood cell substitution enables preservation for one week with a fully automated NMP device

Dr. Rozita Khodashahi, Iran Oral
The association of hepatic artery resistive index and graft failure; Analysis of various cut-off values

Dr. Kazuki Sasaki, Japan Oral
The short- and long-term outcomes of steroid-free regimen in liver transplantation

Dr. Sunghae Park, Korea Oral
Impact of donor hepatic duct bifurcation location and angle on post-transplant biliary complications in recipients following living donor liver transplantation